Phase II study of paclitaxel plus carboplatin in patients with advanced carcinoma of the urothelium and renal dysfunction (E2896): A Trial of the Eastern Cooperative Oncology Group

Chemotherapy options for the patients with advanced urothelial carcinoma and renal dysfunction are limited. The authors performed a Phase II trial of paclitaxel plus carboplatin in patients with advanced carcinoma of the urothelium and renal dysfunction. Forty-two patients were accrued; 37 eligible...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer 2002-09, Vol.95 (5), p.1022-1027
Hauptverfasser:	VAUGHN, David J, MANOLA, Judith, DREICER, Robert, SEE, William, LEVITT, Ralph, WILDING, George
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Carboplatin - administration & dosage Carcinoma - drug therapy Carcinoma - pathology Chemotherapy Female Humans Infusions, Intravenous Kidney Diseases - complications Male Medical sciences Middle Aged Paclitaxel - administration & dosage Pharmacology. Drug treatments Prognosis Survival Analysis Urinary Bladder Neoplasms - drug therapy Urinary Bladder Neoplasms - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!